Buca, Baby Boy .

HRN: 27-51-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/27/2025
08/03/2025
IV
35mg
Q24
PSNB
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: